This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The Perils Of Trading Too Often

By Robert Freedland

Some years ago, I was introduced to a marvelous book by Robert Lichello called “How to Make $1,000,000 in the Stock Market Automatically.” What intrigued me about the book was the ‘automatic’ nature of the investing process.

To be clear, the Covestor Sustained Momentum portfolio is not based on the Lichello Strategy, which involves shifting between a mutual fund and a cash account based on underlying market performance.

There is a famous study by Terry Odean from Berkeley who studied trades of amateurs. The bottom line is that over-trading reduced performance. I can relate to that observation. Who among us can claim not to feel fear when the stocks swoon or euphoria when they climb?

During the last two months there were no big changes in my portfolio. I sold shares in Colgate (CL) which dropped out of the top eleven and purchased shares in Microsoft (MSFT). Microsoft’s stock hasn’t performed well and was sold. Shares of Colgate were repurchased.

The other ten stocks in the portfolio as of August 31, 2013, include Amazon (AMZN), Walt Disney (DIS), Ford (F), Johnson Controls (JCI), Nordstrom (JWN), Morningstar (MORN), PetSmart (PETM), ResMed (RMD), Meridian Bioscience (VIVO), and Valeant Pharmaceuticals (VRX).

Again, I thank those who have chosen to mirror me in this account and would like to express my sincere appreciation to my friends at Covestor who continue to support me in my own desire to expand upon my investing hobby into something more substantial.

The investments discussed are held in client accounts as of August 31, 2013. These investments may or may not be currently held in client accounts. The reader should not assume that any investments identified were or will be profitable or that any investment recommendations or investment decisions we make in the future will be profitable.

Robert Freedland

Robert Freedland

Robert has over 40 years of investment experience and is a full-time optical surgeon. He uses his expertise in the

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $92.18 -1.10%
FB $119.23 1.20%
GOOG $709.44 1.10%
YHOO $37.17 0.62%
TSLA $215.26 1.80%


Chart of I:DJI
DOW 17,686.22 +25.51 0.14%
S&P 500 2,050.14 -0.49 -0.02%
NASDAQ 4,710.2950 -6.7990 -0.14%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs